About NanoLab

About company

NanoLab brings world-class molecular diagnostics into the point of care market. They have a patent pending device capable of becoming a fully featured platform diagnostic tool. They also have an attractive, $1.2 billion initial market with cardiac enzyme panel tests to diagnose heart attacks. They use nanoscale magnetic sensors and tags to achieve sensitivities over 20 times greater than the current gold standard, with results available in 15 minutes in a purely portable package.